Previous Close | 0.7800 |
Open | 0.7700 |
Bid | 0.7704 x 1200 |
Ask | 0.8300 x 1200 |
Day's Range | 0.7422 - 0.8110 |
52 Week Range | 0.7400 - 3.2200 |
Volume | |
Avg. Volume | 69,190 |
Market Cap | 8.377M |
Beta (5Y Monthly) | 0.63 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.1330 |
Earnings Date | Nov 11, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.88 |
6 million in Q1 including sale of 2,750 consumable treatment tipsPURSUIT trial top-line results anticipated at end of 2022Conference call to be hosted by Company at 5:00 PM ET todayENGLEWOOD, CO / ACCESSWIRE / May 12, 2022/ Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today reported financial results for the quarter ended March 31, 2022, and will provide a corporate update on its scheduled conference call at 5:00 PM ET today.
ENGLEWOOD, CO / ACCESSWIRE / April 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its first quarter 2022 financial results and provide a corporate update after the close of the U.
Reported total revenue for year end 2021 of $6.4 million representing 17% year-over-year growthEnrollment completed in U.